Scientists in Denmark say they’re close to a “promising” breakthrough to cure human immunodeficiency virus, HIV.
Researchers at the Aarhus University Hospital are conducting clinical trials on humans using a “novel strategy” proven effective in laboratory tests. The news came just days after the U.S. government announced failure in a large study to develop a possible HIV vaccine.
The Danish study uses a therapy that flushes the virus from so-called reservoirs it forms within DNA cells, whereupon the body’s immune system — with a little help from a vaccine — can hunt and destroy. Though the therapy appeared effective when using human skin cells in the lab, efficacy in the human body remains unproven, according to Dr. Ole Sogaard, a senior researcher in the department of infectious disease.
“The challenge will be getting the patients’ immune system to recognize the virus and destroy it. This depends on the strength and sensitivity of individual immune systems,” Dr. Sogaard told the media.
At least three Chinese patients have died as a consequence of getting infected by the newest strain of influenza and scientists are already calling for a heightened state of alert given what the strain is capable of doing. The H7N9 virus, which seems not to be able to kill animals, is fatal on humans. The H7N9 strain has never been seen before and seems to use animals as a launching pad to later infect people. Scientists refer to it as a virus with the potential to have major public health significance.
“Chinese scientists are to be congratulated for the apparent speed with which the H7N9 virus was identified,” write their counterparts at the Centers for Disease Control (CDC). It is so, because the Chinese scientists managed to sequence the whole viral genome to then make them public and available so other scientists can investigate further. “Because this H7N9 virus has not been detected in humans or animals previously, the situation raises many urgent questions and global public health concerns.”
Scientists now will concentrate on analyzing whether the virus has any chance of jumping from person to person, or if its capacity to spread is limited to going from an infected animal to a person. If the first scenario is true, it would set the stage for a potential global pandemic with a ‘sustained human-to-human transmission’. Scientists are also working on determining transmission dynamics, modes, basic reproductive number, and incubation period for the virus strain.
Read more important information here: http://www.thesleuthjournal.com/new-influenza-strain-might-signal-the-start-of-a-pandemic/
It’s nice to know that I can blame a virus now instead of Mc Donald’s if I get fat!
Adenovirus serotype 36
From Wikipedia, the free encyclopedia
|Adenovirus serotype 36|
There has been a positive correlation between body fat and the presence of AD-36 antibodies in the blood . Previous research showed that chicken or mice injected with similar types of viruses show a statistically significant weight gain.
To date, AD-36 is the only human adenovirus that has been linked with human obesity, present in 30% of obese humans and 11% of nonobese humans. AD-36 also causes obesity in chickens, mice, rats, and monkeys.
On March 18, 2006 the research of Richard Atkinson (University of Wisconsin) was posted on some websites. In those studies, blood tests conducted on over 2000 Australians showed that more than 20% of the study participants had contracted Ad-36 viral infection.
On January 26, 2009, many popular internet news portals ran reports of the pending release of scientific research by Professor Nikhil Dhurandhar (Pennington Biomedical Research Centre, Louisiana) implicating AD-36 as a potential cause for Britain’s relatively high rate of adult obesity.